TRPM7 kinase is required for insulin production and compensatory islet responses during obesity

JCI Insight. 2023 Feb 8;8(3):e163397. doi: 10.1172/jci.insight.163397.

Abstract

Most overweight individuals do not develop diabetes due to compensatory islet responses to restore glucose homeostasis. Therefore, regulatory pathways that promote β cell compensation are potential targets for treatment of diabetes. The transient receptor potential cation channel subfamily M member 7 protein (TRPM7), harboring a cation channel and a serine/threonine kinase, has been implicated in controlling cell growth and proliferation. Here, we report that selective deletion of Trpm7 in β cells disrupted insulin secretion and led to progressive glucose intolerance. We indicate that the diminished insulinotropic response in β cell-specific Trpm7-knockout mice was caused by decreased insulin production because of impaired enzymatic activity of this protein. Accordingly, high-fat-fed mice with a genetic loss of TRPM7 kinase activity displayed a marked glucose intolerance accompanied by hyperglycemia. These detrimental glucoregulatory effects were engendered by reduced compensatory β cell responses because of mitigated protein kinase B (AKT)/ERK signaling. Collectively, our data identify TRPM7 kinase as a potentially novel regulator of insulin synthesis, β cell dynamics, and glucose homeostasis under obesogenic diet.

Keywords: Beta cells; Cell Biology; Insulin; Ion channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glucose
  • Glucose Intolerance*
  • Insulin / metabolism
  • Mice
  • Mice, Knockout
  • Obesity
  • Protein Serine-Threonine Kinases / metabolism
  • TRPM Cation Channels* / genetics
  • TRPM Cation Channels* / metabolism

Substances

  • Glucose
  • Insulin
  • Protein Serine-Threonine Kinases
  • TRPM Cation Channels
  • Trpm7 protein, mouse